Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Predictors of response to opicinumab in acute optic neuritis.

Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch LJ, Leocani L, Freedman MS, Plant GT, Preiningerova JL, Ziemssen F, Massacesi L, Chai Y, Xu L; RENEW Study Investigators.

Ann Clin Transl Neurol. 2018 Aug 15;5(10):1154-1162. doi: 10.1002/acn3.620. eCollection 2018 Oct.

2.

Deletion of Maged1 in mice abolishes locomotor and reinforcing effects of cocaine.

De Backer JF, Monlezun S, Detraux B, Gazan A, Vanopdenbosch L, Cheron J, Cannazza G, Valverde S, Cantacorps L, Nassar M, Venance L, Valverde O, Faure P, Zoli M, De Backer O, Gall D, Schiffmann SN, de Kerchove d'Exaerde A.

EMBO Rep. 2018 Sep;19(9). pii: e45089. doi: 10.15252/embr.201745089. Epub 2018 Jul 12.

PMID:
30002119
3.

A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.

Laureys G, Willekens B, Vanopdenbosch L, Deryck O, Selleslag D, D'Haeseleer M, De Becker A, Dubois B, Dierickx D, Perrotta G, De Wilde V, van Pesch V, Straetmans N, Dive D, Beguin Y, Van Wijmeersch B, Theunissen K, Kerre T, Van de Velde A.

Acta Neurol Belg. 2018 Jun;118(2):161-168. doi: 10.1007/s13760-018-0905-0. Epub 2018 Mar 13.

4.

Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.

Lambert C, Dubois B, Dive D, Lysandropoulos A, Selleslag D, Vanopdenbosch L, Van Pesch V, Vanwijmeersch B, Janssens A.

Acta Neurol Belg. 2018 Mar;118(1):141. doi: 10.1007/s13760-018-0899-7.

PMID:
29500681
5.

Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.

Lambert C, Dubois B, Dive D, Lysandropoulos A, Selleslag D, Vanopdenbosch L, Van Pesch V, Vanwijmeersch B, Janssens A.

Acta Neurol Belg. 2018 Mar;118(1):7-11. doi: 10.1007/s13760-018-0882-3. Epub 2018 Jan 27. Erratum in: Acta Neurol Belg. 2018 Mar 3;:.

6.

Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensus.

Sprangers B, Decoo D, Dive D, Lysandropoulos A, Vanopdenbosch L, Bovy C.

Acta Neurol Belg. 2018 Jun;118(2):143-151. doi: 10.1007/s13760-017-0864-x. Epub 2017 Nov 30.

7.

Association of Cerebral Venous Thrombosis and Intracranial Hypotension: Review of 3 Cases.

Sinnaeve L, Vanopdenbosch L, Paemeleire K.

J Stroke Cerebrovasc Dis. 2017 Aug;26(8):e165-e169. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.015. Epub 2017 Jun 13.

PMID:
28623115
9.

Corticosteroids in the management of acute multiple sclerosis exacerbations.

Smets I, Van Deun L, Bohyn C, van Pesch V, Vanopdenbosch L, Dive D, Bissay V, Dubois B; Belgian Study Group for Multiple Sclerosis.

Acta Neurol Belg. 2017 Sep;117(3):623-633. doi: 10.1007/s13760-017-0772-0. Epub 2017 Apr 8. Review.

PMID:
28391390
10.

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.

Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, Frederiksen J, Skeen M, Jaffe GJ, Butzkueven H, Ziemssen F, Massacesi L, Chai Y, Xu L, Freeman S; RENEW Study Investigators.

Lancet Neurol. 2017 Mar;16(3):189-199. doi: 10.1016/S1474-4422(16)30377-5. Epub 2017 Feb 15.

PMID:
28229892
11.

Palliative Care in Multiple Sclerosis.

Vanopdenbosch LJ, Oliver DJ, Kass JS.

Continuum (Minneap Minn). 2016 Jun;22(3):943-6. doi: 10.1212/CON.0000000000000321.

PMID:
27261690
12.

Bing-Neel syndrome: Two unexpected cases and a review of the literature.

Van Cauwenberge MG, Depreter B, Dumoulin EN, Emmerechts J, Nollet F, Vanopdenbosch LJ.

J Neurol Sci. 2015 Sep 15;356(1-2):19-26. doi: 10.1016/j.jns.2015.06.026. Epub 2015 Jun 16. Review.

PMID:
26159625
13.

Multiple nocardial abscesses of the brainstem and spinal cord diagnosed after an open biopsy through a cervical partial central corpectomy: case report.

Peeters I, Casselman JW, Vandecasteele SJ, Janssen A, Regaert B, Vantomme N, Vanopdenbosch LJ.

J Neurosurg Spine. 2015 Sep;23(3):290-3. doi: 10.3171/2014.12.SPINE14755. Epub 2015 Jun 19.

PMID:
26091435
14.

Pseudotumoral rebound of multiple sclerosis in a pregnant patient after stopping natalizumab.

Verhaeghe A, Deryck OM, Vanopdenbosch LJ.

Mult Scler Relat Disord. 2014 Mar;3(2):279-81. doi: 10.1016/j.msard.2013.10.001. Epub 2013 Oct 3.

PMID:
25878019
15.

Are atraumatic spinal needles as efficient as traumatic needles for lumbar puncture?

Pelzer N, Vandersteene J, Bekooij TJ, Schoonman GG, Wirtz PW, Vanopdenbosch LJ, Koppen H.

Neurol Sci. 2014 Dec;35(12):1997-9. doi: 10.1007/s10072-014-1924-0. Epub 2014 Aug 20.

PMID:
25139108
16.

Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.

van Pesch V, Bartholomé E, Bissay V, Bouquiaux O, Bureau M, Caekebeke J, Debruyne J, Declercq I, Decoo D, Denayer P, De Smet E, D'hooghe M, Dubois B, Dupuis M, Sankari SE, Geens K, Guillaume D, van Landegem W, Lysandropoulos A, de Noordhout AM, Medaer R, Melin A, Peeters K, Ba RP, Retif C, Seeldrayers P, Symons A, Urbain E, Vanderdonckt P, Van Ingelghem E, Vanopdenbosch L, Vanroose E, Van Wijmeersch B, Willekens B, Willems C, Sindic C.

Acta Neurol Belg. 2014 Sep;114(3):167-78. doi: 10.1007/s13760-014-0308-9. Epub 2014 Jun 11.

PMID:
24915752
17.

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.

Cambron M, Mostert J, Haentjens P, D'Hooghe M, Nagels G, Willekens B, Heersema D, Debruyne J, Van Hecke W, Algoed L, De Klippel N, Fosselle E, Laureys G, Merckx H, Van Wijmeersch B, Vanopdenbosch L, Verhagen W, Hupperts R, Hengstman G, Michiels V, Van Merhaegen-Wieleman A, De Keyser J.

Trials. 2014 Jan 25;15:37. doi: 10.1186/1745-6215-15-37.

18.

Anti-glycine receptor antibody mediated progressive encephalomyelitis with rigidity and myoclonus associated with breast cancer.

De Blauwe SN, Santens P, Vanopdenbosch LJ.

Case Rep Neurol Med. 2013;2013:589154. doi: 10.1155/2013/589154. Epub 2013 Jul 10.

19.

MRI characteristics of trigeminal nerve involvement in patients with multiple sclerosis.

Swinnen C, Lunskens S, Deryck O, Casselman J, Vanopdenbosch L.

Mult Scler Relat Disord. 2013 Jul;2(3):200-3. doi: 10.1016/j.msard.2012.12.002. Epub 2013 Jan 10.

PMID:
25877726
20.

Resolution of abnormal fractional anisotropy of substantia nigra in organophosphate intoxication.

Swinnen C, Vanacker P, Casselman J, Van Zandijcke M, Vanopdenbosch L.

Acta Neurol Belg. 2011 Dec;111(4):378. No abstract available.

PMID:
22368991
21.

Vascular aspects of multiple sclerosis.

D'haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J.

Lancet Neurol. 2011 Jul;10(7):657-66. doi: 10.1016/S1474-4422(11)70105-3. Review.

PMID:
21683931
22.

Toxocariasis presenting as encephalomyelitis.

Helsen G, Vandecasteele SJ, Vanopdenbosch LJ.

Case Rep Med. 2011;2011:503913. doi: 10.1155/2011/503913. Epub 2011 May 5.

23.

Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.

Verhelst X, Vanhooren G, Vanopdenbosch L, Casselman J, Laleman W, Pirenne J, Nevens F, Orlent H.

Transpl Int. 2011 Apr;24(4):e30-4. doi: 10.1111/j.1432-2277.2010.01190.x. Epub 2010 Dec 7. Review.

24.

Art, medicine and surgery: puncture of ascites.

Van Hee R, Dequeker J, Vanopdenbosch L.

Acta Chir Belg. 2010 Jul-Aug;110(4):492-7. No abstract available.

PMID:
20919677
25.

MRI with intrathecal gadolinium to detect a CSF leak: a prospective open-label cohort study.

Vanopdenbosch LJ, Dedeken P, Casselman JW, Vlaminck SA.

J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):456-8. doi: 10.1136/jnnp.2009.180752. Epub 2010 Jun 20.

PMID:
20562454
26.

Post-traumatic pulsatile tinnitus: the hallmark of a direct carotico-cavernous fistula.

Lerut B, De Vuyst C, Ghekiere J, Vanopdenbosch L, Kuhweide R.

J Laryngol Otol. 2007 Nov;121(11):1103-7. Epub 2007 Feb 13.

PMID:
17295936
27.

Linezolid-induced inhibition of mitochondrial protein synthesis.

De Vriese AS, Coster RV, Smet J, Seneca S, Lovering A, Van Haute LL, Vanopdenbosch LJ, Martin JJ, Groote CC, Vandecasteele S, Boelaert JR.

Clin Infect Dis. 2006 Apr 15;42(8):1111-7. Epub 2006 Mar 13.

PMID:
16575728
28.

The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis.

Régal L, Vanopdenbosch L, Tilkin P, Van den Bosch L, Thijs V, Sciot R, Robberecht W.

Arch Neurol. 2006 Feb;63(2):262-7. Erratum in: Arch Neurol. 2006 Jul;63(7):963.

PMID:
16476815
29.

Bell's palsy with ipsilateral numbness.

Vanopdenbosch LJ, Verhoeven K, Casselman JW.

J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):1017-8.

30.

Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration.

Van Den Bosch L, Storkebaum E, Vleminckx V, Moons L, Vanopdenbosch L, Scheveneels W, Carmeliet P, Robberecht W.

Neurobiol Dis. 2004 Oct;17(1):21-8.

PMID:
15350962
31.

Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy.

Boelaert JR, Goddeeris KH, Vanopdenbosch LJ, Casselman JW.

AIDS. 2004 May 21;18(8):1223-4. No abstract available.

PMID:
15166545
32.
33.

Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.

Vanopdenbosch L, Dubois B, D'Hooghe MB, Meire F, Carton H.

J Neurol. 2000 Jul;247(7):535-43.

PMID:
10993496
34.

Leão's cortical spreading depression and the somatosensory homunculus: a contradiction?

Vanopdenbosch L, Herroelen L.

Headache. 1998 Apr;38(4):322-3. No abstract available.

PMID:
9595876
35.

Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease.

Demaerel P, Baert AL, Vanopdenbosch L, Robberecht W, Dom R.

Lancet. 1997 Mar 22;349(9055):847-8. No abstract available.

PMID:
9121263
36.

Early evidence of scleroderma.

Dequeker J, Vanopdenbosch L, Ojugas AC.

BMJ. 1995 Dec 23-30;311(7021):1714-5. No abstract available.

Supplemental Content

Loading ...
Support Center